Просто «таблетка». Шестьдесят лет открытий и достижений, которые изменили мир. Часть I. гормональная контрацепция: от идеи к совершенству
- Авторы: Дикке Г.Б1
-
Учреждения:
- Академия медицинского образования им. Ф.И. Иноземцева
- Выпуск: Том 27, № 6 (2020)
- Страницы: 10-17
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/312667
- DOI: https://doi.org/10.18565/pharmateca.2020.6.10-17
- ID: 312667
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Настоящий обзор литературы представляет собой очерк истории развития гормональной контрацепции со времени появления идеи предупреждения беременности и далее на протяжении 60 лет от выпуска первой контрацептивной «таблетки» до наших дней.
Ключевые слова
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
Г. Б Дикке
Академия медицинского образования им. Ф.И. Иноземцева
Email: galadikke@yandex.ru
д.м.н., доцент, профессор кафедры акушерства и гинекологии с курсом репродуктивной медицины
Список литературы
- Феррис П. Зигмунд Фрейд. Пер. с англ. Е. Мартинкевич. Мн.: Попурри. 2001. 448 с. [Ferris P Sigmund Freud. Translation from English E. Martinkevich. Mn.: Potpourri. 2001. 448 p. (in Russ.)].
- Сакевич В.И. 60 лет Международной Федерации планируемого родительства. Демоскоп Weekly. 2012;531-32 [Sakevich Vi. 60 years of the international Planned Parenthood Federation. Demoscope Weekly. 2012;531-32. (in Russ.)]. http://www.demoscope.ru/weekly.
- Sanger M. Morality and Birth Control. Birth Control Review. 1918 February-March: 11-4. https://ru.citaty.net.
- Henderson J. A Life of Ernest Starling. Oxford University Press. 2005. 229 р.
- Weintraub B. Pincus, Djerassi and Oral Contraceptives. Chemistry in Israel. Bulletin of the Israel Chemical Society. August 2005.
- Pletzer B.A., Kerschbaum H.H. 50 years of hormonal contraception-time to find out, what it does to our brain. Front Neurosci. 2014;8:256. doi: 10.3389/fnins.2014.00256.
- Casey C.L., Murray C.A. HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clin interv Aging. 2008;3(1):9-16. doi: 10.2147/cia.s1663.
- Liao P.V., Dollin J. Half a century of the oral contraceptive pill: historical review and view to the future. Can Fam Physician. 2012;58(12): e757-60.
- Gibbs N. Time Executive Editor. Time Magazine, May 3, 2010.
- Демографическая модернизация России 1900-2000. Под ред. А.В. Вишневского. М., 2006. 608 с. [Demographic modernization of Russia 1900-2000. Ed. by A.V. Vishnevsky. M., 2006. 608 p. (in Russ.)].
- Marrs С., Gomer К. Nelson Pill Hearings Annotated. Research. Lucine Health Sciences, INC. 2016. Р. 5921-6445. Doi: 10.13140/ RG.2.2.32749.64489.
- Rabe T., Luxembourg B., Ludwig M., et al. Contraception and Thrombophilia - A statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.). J Reprodukt Endokrinol. 2011;8(Special issue 1):178-218.
- Burkman R., Bell C., Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception. 2011; 84(1):19-34.
- Chernick B.A. Side effects of cyclic therapy with norethindrone and mestranol. Fertil Steril. 1965;16(4):445-54.
- Schindler A.E., Campagnoli C., Druckmann R., et al. Classification and pharmacology of progestins. Maturitas. 2008;61(1):171-80.
- Rice-Wray E., Avila C., Gutirrez J. Norgestrel and ethynyl estradiol: a new low-dosage oral agent for fertility control. Obstet Gynecol. 1968; 31(3):368-74.
- Ismail M.T. A randomised comparative study of Triquilar versus Marvelon: the Malaysian experience. Malays J Reprod Health. 11991;9(1):9-17.
- Zador G., Nilsson B.A., Nilsson B., et al. Clinical experience with the uterine progesterone system (Progestasert R). Contraception. 1976;13(5):559-69.
- Nelson A.L., Massoudi N. New developments in intrauterine device use: focus on the US. Open Access. J Contracept. 2016;7:127-41. doi: 10.2147/0AJC.S85755
- Fotherby K, Trayner i., Longthorne PN., et al. Metabolic investigations with Femodene -an oral contraceptive containing gestodene and ethinyloestradiol. Contraception. 1987;35(4):323-37.
- Bringer J. Norgestimate: a clinical overview of a new progestin. Am J Obstet Gynecol. 1992;166(6 Pt. 2):1969-77.
- Etonogestrel. Drugs and Lactation Database (LactMed) [internet]. Bethesda (MD): National Library of Medicine (US); 2006. https://www. nchLnim.nih.gch/pubmeb/30QG0572.
- Ruan X.,Seeger H., Mueck A.O. The pharmacology of dienogest. Maturitas. 2712;71(4):GG7-44. doi: 17.1716/j./ateritas.2712.71.718.
- Rapkin A.J., Sorger S.N., Winer S.A. Drospirenone/ethinyl estradiol. Drugs Today (Barc). 2228;44(2):1GG-45. Doi: 17.1358/ dot.2008.44.2.1191057.
- Mueck A.O., Sitruk-Ware R. Nomegestrolacetate, a novel progestogen for oral contraception. Steroids. 2711;76(6):531-39. Doi: 17.1716/j. steroids.
- Lidegaard 0., L0kkegaard E., Svendsen A.L., Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.
- Parke S., Junge W., Mellinger U., et al. Oral Comparative effects of a four-phasic regimen of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel on haemostatic parameters. Hum Reprod. 2228;2G(Suppl. 1):i77-i78.
- Ågren U.M., Anttila M., Mäenpää-Liukko K., et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 2011; 16:444-57.
- Zeun S., Lu M., Uddin A., et al. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2009;14(3):221-32.
- Agren U.M., Anttila M., Maenpaa-Liukko K., et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17/3-oestradiol compared with one containing levonorgestrel and ethinyiestra0ioi on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 2011;16(6): 444-57.
- Jensen J.T. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest. Expert Opin Phamacother. 2010;11(7): 1147-57.
- Duijkers I.J., Klipping C., Grob P, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care. 2010; 15(5):314-25.
- Mansour D., Verhoeven C., Sommer W., etal. Efficacy and tolerability of a monophasiccombined oral contraceptive containingnomegestrol acetate and 17β-oestradiolin a 24/4 regimen, in comparison to an oralcontraceptive containing ethinylestradiol anddrospirenone in a 21/7 regimen. Eur J ContraceptReprod Health Care. 2011;16(6):430-43
- Westhoff C., Kaunitz A.M., Korver T., et al. Efficacy,safety, and tolerability of a monophasic oral contraceptive containing nomegestrolacetate and 17β-estradiol: a randomized controlledtrial. Obstet Gynecol. 2012;119(5):989-99
- Dinger J., Do Minh T., Heinemann K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception. 2016;95(5):328-39. Doi: 0.1016/j. contraception.2016.06.010.
- Graziottin A. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval. Eur J Contracept Reprod Health Care. 2016;21(2):93-105. Doi: 10.3 1 09/13 625187.20 1 5.10 77380.
- Grandi G., Xholli A., Napolitano A., et al. Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol. Contraception. 2015;90(5):529-35. Doi: 10.1016/j. contraception.2014.05.011.
- Burness C.B. Extended-Cycle Levonorgestrel/ Ethinyiestra0ioi and Low-Dose Ethinylestradiol (Seasonique): A Review of Its Use as an Oral Contraceptive. Drugs. 2015;75(9):1019-26. doi: 10.1007/s40265-015-0407-9.
- Nau J.Y. Lybrel and menstrual cessation. Rev Med Suisse. 2007;3(110):1209.
- Elliesen J., Trummer D. Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studies. Int J Womens Health. 2016;8:351-56. doi: 10.2147/IJWH. S107516.
- Bennett J.P The Second Generation of Hormonal Contraceptives. In: Chemical Contraception. Palgrave, London; 1974. Р 39-62. doi: 10.1007/978-1-349-02287-8_4.
- Bruess C.E., Oswalt S.B. Exploring the Dimensions of Human Sexuality. Jones & Bartlett Publishers; 2016. 824 p.
- French K. Sexual Health. John Wiley & Sons; 2009. Р 92-3.
- Lortscher D., Admani S., Satur N., Eichenfied L.F. Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients. J Drugs Dermatol. 2016;15(6):670-75.
- Ahrendt H.J., Makalova D., Parke S., Mellinger U., Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception. 2009;80(5):536-55. Doi: 10.1016/j. contraception.2009.03.018.
- Fraser I.S., Parke S., Mellinger U., et al. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contraception Reprod Health Care. 2011;16: 258-69.
- Kaunitz A.M., Bissonnette F., Monteiro I., et al. Levonorgestrel-releasing intrauterine system or medroxy-progesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(3):625-32.
- Pearlstein T.B., Bachmann G.A., Zacur H.A., Yonkers K.A. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulatOon. Contraception. 2005;72(6):414-21.
- Rapkin R.B., Creinin M.D. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium. Expert Opin Pharmacother. 2011;12(15):2403-10. doi: 10.1517/14656566.2011.610791.
- Sitruk-Ware R, Nath A., Mishell D.R. Contraception technology: past, present and future. Contraception. 2013;87(3):319-30. doi: 10.1016/j.contraception.2012.08.002
Дополнительные файлы
![](/img/style/loading.gif)